ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.667,83
0,85%
S&P 500
6.032,38
0,56%
US Dollar vs BRL
5,97435
0,00%
Bitcoin
96.404,24
-1,11%
Brent Oil
71,98
-0,08%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Vascular Biogenics Ltd (VBLT)

  7. Vascular Biogenics Ltd (VBLT) Notícias

VBLT

Vascular Biogenics (VBLT)

Vascular Biogenics Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:VBLT
DataHoraFonteTítuloCódigoCompanhia
19/09/202417:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
29/08/202417:06Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
14/08/202417:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBLTVascular Biogenics Ltd
09/08/202417:01Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
20/06/202418:01Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:VBLTVascular Biogenics Ltd
10/05/202418:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
19/04/202417:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VBLTVascular Biogenics Ltd
11/04/202418:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VBLTVascular Biogenics Ltd
01/04/202417:30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:VBLTVascular Biogenics Ltd
16/02/202411:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
05/02/202419:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
11/01/202419:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
08/01/202418:21Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:VBLTVascular Biogenics Ltd
29/11/202319:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
26/10/202318:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/10/202318:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VBLTVascular Biogenics Ltd
19/10/202314:34Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:VBLTVascular Biogenics Ltd
17/10/202318:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VBLTVascular Biogenics Ltd
10/10/202309:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:VBLTVascular Biogenics Ltd
02/10/202318:29Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VBLTVascular Biogenics Ltd
06/09/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VBLTVascular Biogenics Ltd
05/09/202316:52Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
09/06/202317:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:VBLTVascular Biogenics Ltd
15/05/202317:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VBLTVascular Biogenics Ltd
15/05/202317:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VBLTVascular Biogenics Ltd
18/04/202317:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VBLTVascular Biogenics Ltd
14/03/202309:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VBLTVascular Biogenics Ltd
09/12/202219:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:VBLTVascular Biogenics Ltd
18/11/202208:15TipRanksH.C. Wainwright Reaffirms Their Hold Rating on Vascular Biogenics (VBLT)NASDAQ:VBLTVascular Biogenics Ltd
20/07/202209:55TipRanksVascular Biogenics (VBLT) Receives a Hold from JonesTradingNASDAQ:VBLTVascular Biogenics Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:VBLT

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
ATOM3
ATOMPAR ON
BOV
IDIV
Dividend
BOV
AZEV4
AZEVEDO PN
BOV
BRFS3
BRF S/A ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Economize até 50%* para TRADER PLUS

1 ano 30%, 2 anos 40% e *3 anos 50%

*Ao longo de 3 anos $ 1475.65 apenas $ 737.82